Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours
Clinical trial NCT04808362 · TERMINATED
Trial details
- NCT number
- NCT04808362
- Sponsor
- Peptomyc S.L.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-28
- Primary completion
- 2022-12-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.